Palisade Capital Management LLC Aerie Pharmaceuticals Inc Transaction History

Palisade Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$47.85 - $70.45 $574,200 - $845,400	-12,000 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$51.15 - $61.0 $97,185 - $115,900	1,900 Added 18.81%	12,000 $651,000
Q4 2017 Feb 09, 2018	BUY	$50.85 - $65.1 $297,472 - $380,834	5,850 Added 137.65%	10,100 $603,000
Q3 2017 Oct 31, 2017	BUY	$48.6 - $60.1 $206,550 - $255,425	4,250	4,250 $207,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.